Tailor-made medicines could be biased towards affluent white men

Mar 13, 2018, 4:39 AM EDT
(Source: Sam-Cat/flickr)
(Source: Sam-Cat/flickr)

The idea that one-size-fits-all medicine of today would be replaced by precision drugs based on a person’s genetics, ethnicity, diet, etc. sounds great but is likely to favor only the affluent white men, according to a study by the Data & Society Research Institute in New York.

The uninsured, the health-illiterate, women, minorities and immigrants constitute the under-represented sections in the datasets used by researchers working on precision drugs, which inherently pushes a bias, notes MIT Technology Review.

The affluent white men, who can afford health insurance, lead a decent lifestyle, have access to latest health technologies and with a general proximity to research hubs, unwittingly get a bigger say in the development of future medications.